Medtronic and Lifetech Scientific expand their deal to co-produce pacemakers for the Chinese market.
Merit Medical says the Chinese FDA granted approval for its Aero tracheobronchial stent, marking its Endotek division's 1st entry into the People's Republic.
More than 2 years after inking a $22 million deal to settle charges that it violated the Foreign Corrupt Practices Act, Biomet says the SEC issued a subpoena over alleged "improprieties" in Brazil and Mexico.
Intuitive Surgical says it's shifting from distribution to direct sales for its da Vinci surgical robot in Japan.
Chinese regulators put their stamp of approval on Sorin Group's and MicroPort Scientific's joint venture for cardiac rhythm devices.
Johnson & Johnson's Ethicon Biosurgery business plans to add 270 jobs to its manufacturing operation in Ireland.
Johnson & Johnson (NYSE:JNJ) plans to add 270 jobs to its Ethicon Biosurgery operation in Ireland, according to the Irish Times.
Medtronic details its humanitarian sales to Syria, Cuba and Sudan to the U.S. Securities & Exchange Commission.
The U.S. Securities & Exchange Commission closed its review of Medtronic's sales to strife-torn Syria and Sudan and to Cuba, which the medical device company said are made on a humanitarian basis and amount to a small fraction of its total business.
The SEC asked Medtronic in January to explain its business contacts in the 3 nations, which are flagged as state sponsors of terrorism and are subject to U.S. economic sanctions and assets controls.